Skip to main content
Caplight Logo









Scailyte AG

Scailyte AG

Private
BaselHealthcare & Life Scienceshttps://www.scailyte.com/

Last Round

Series A

Extension

Dec 4, 2023

Total Funding Raised

$14.04M

Company Overview

Scailyte AG is a biotechnology company that provides an artificial intelligence platform for the discovery of complex disease patterns from single-cell data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

biomarker discoverysingle-cell analysisAI drug discoverypatient stratificationCDxcompanion diagnosticsprecision medicinespatial omicsbiotech AImulti-omicsclinical trial optimizationoncologyimmunologyInflammatory Bowel DiseaseIBD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scailyte AG Comparables

Compare Scailyte AG with similar companies based on industry and business-model similarity.

Scailyte AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abiosciences
86%
One Biosciences
86%
Sonrai Analytics
83%

Scailyte AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 4, 2023
Series ASep 21, 2022
SeedJun 9, 2020
SeedDec 19, 2018

Key People

Founding team and executive leadership

Peter Nestorov

Co-Founder and CEO

Founding Team

Scailyte AG Investors

Notable investors and investment history

Scailyte AG investors
InvestorRounds
Swisscom VenturesSeries A, Seed
4FOX VenturesSeries A, Seed
Venture KickGrant
Mirabaud SecuritiesSeries A
Zurcher KantonalbankSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors increased 136% MoM, reaching 2.6K.

  • Nov 14, 2024

    Monthly visitors increased 98% MoM.

Scailyte AG Filings

Explore SEC and related filing metadata, where available.

Scailyte AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scailyte AG's valuation, stock price, and market status.

Is Scailyte AG a public or private company?

Scailyte AG is a private company.

What is the current stock price of Scailyte AG?

Scailyte AG is a private company with no public stock price. No recent secondary market data is available.

How much is Scailyte AG worth (valuation)?

Valuation information for Scailyte AG is not publicly available.

Can I buy Scailyte AG stock?

Scailyte AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scailyte AG's last funding round?

Scailyte AG's most recent funding round was Series A Extension on December 4, 2023.

Who are the main investors in Scailyte AG?

Key investors in Scailyte AG include Swisscom Ventures, Mirabaud Securities.

Will Scailyte AG IPO soon?

No public IPO plans have been announced for Scailyte AG.

How can I track Scailyte AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scailyte AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range15
Year Founded2017
Last FundingDec 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?